Adverse effects of oral second-line antituberculosis drugs in children-Reference-Cited by-同舟云学术

Adverse effects of oral second-line antituberculosis drugs in children

Published:2016-08-05 Issue:10 Volume:15 Page:1369-1381
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Schaaf H. Simon¹,Thee Stephanie²,van der Laan Louvina¹,Hesseling Anneke C.¹,Garcia-Prats Anthony J.¹

Affiliation:

1. Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa

2. Department of Paediatric Pneumology and Immunology, Charité, Universitätsmedizin Berlin, Berlin, Germany

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2016.1216544

Reference132 articles.

1. Global burden of drug-resistant tuberculosis in children: a mathematical modelling study

2. Towards early inclusion of children in tuberculosis drugs trials: a consensus statement

3. Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru

4. Caring for Children with Drug-Resistant Tuberculosis

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-induced hypothyroidism in tuberculosis;Expert Review of Endocrinology & Metabolism;2024-01-23

2. Tolerability of Tuberculosis Chemotherapy in Children;Tuberculosis and Lung Diseases;2023-12-24

3. Optimizing dosing of the cycloserine pro-drug terizidone in children with rifampicin-resistant tuberculosis;Antimicrobial Agents and Chemotherapy;2023-12-14

4. Current Treatment of Drug-Resistant Tuberculosis in Children;Indian Journal of Pediatrics;2023-11-23

5. New Drugs and Regimens for Tuberculosis Disease Treatment in Children and Adolescents;Journal of the Pediatric Infectious Diseases Society;2022-10-01